NO20074361L - Lacosamid for "add-on"-terapi - Google Patents
Lacosamid for "add-on"-terapiInfo
- Publication number
- NO20074361L NO20074361L NO20074361A NO20074361A NO20074361L NO 20074361 L NO20074361 L NO 20074361L NO 20074361 A NO20074361 A NO 20074361A NO 20074361 A NO20074361 A NO 20074361A NO 20074361 L NO20074361 L NO 20074361L
- Authority
- NO
- Norway
- Prior art keywords
- lacosamide
- therapy
- add
- treatment
- antipsychotic
- Prior art date
Links
- VPPJLAIAVCUEMN-GFCCVEGCSA-N lacosamide Chemical compound COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1 VPPJLAIAVCUEMN-GFCCVEGCSA-N 0.000 title 1
- 229960002623 lacosamide Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 2
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64741005P | 2005-01-28 | 2005-01-28 | |
| EP05001843A EP1688137A1 (en) | 2005-01-28 | 2005-01-28 | SPM 927 for add-on therapy of schizophrenia |
| PCT/EP2006/000722 WO2006079547A2 (en) | 2005-01-28 | 2006-01-27 | Spm 927 for add-on therapy of schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074361L true NO20074361L (no) | 2007-10-26 |
Family
ID=36636204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074361A NO20074361L (no) | 2005-01-28 | 2007-08-27 | Lacosamid for "add-on"-terapi |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1841417A2 (pt) |
| JP (1) | JP2008528532A (pt) |
| KR (1) | KR20070096058A (pt) |
| AR (1) | AR057643A1 (pt) |
| AU (1) | AU2006208630B2 (pt) |
| BR (1) | BRPI0607043A2 (pt) |
| CA (1) | CA2595330A1 (pt) |
| EA (1) | EA015566B1 (pt) |
| IL (1) | IL183973A0 (pt) |
| MX (1) | MX2007009070A (pt) |
| NO (1) | NO20074361L (pt) |
| WO (1) | WO2006079547A2 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
| EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
| EA019757B1 (ru) | 2006-06-15 | 2014-06-30 | ЮСиБи ФАРМА ГМБХ | Фармацевтическая композиция с синергетическим противосудорожным эффектом |
| CN101466390B (zh) * | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
| WO2009053070A1 (en) | 2007-10-23 | 2009-04-30 | Schwarz Pharma Ag | Compounds for treating demyelination conditions |
| US20100151021A1 (en) * | 2008-12-16 | 2010-06-17 | Venkatesh Gopi M | Compositions Comprising Melperone |
| EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
| BR112013013525A2 (pt) | 2010-12-02 | 2016-10-18 | Ucb Pharma Gmbh | formulação de liberação controlada sólida de lacosamida para administração oral, composição farmacêutica sólida, e, método para a prevenção, alívio e/ou tratamento de uma doença do sistema nervoso central |
| ES2769286T3 (es) | 2016-12-20 | 2020-06-25 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina |
| WO2018115010A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| ES2881783T3 (es) | 2017-06-26 | 2021-11-30 | Lts Lohmann Therapie Systeme Ag | Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona |
| AU2018378348B2 (en) | 2017-12-05 | 2024-09-19 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| CA3084953A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| CN112533593A (zh) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
| US5773475A (en) * | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
| DE60120104T2 (de) | 2001-03-20 | 2006-09-21 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz |
| DK1243263T3 (da) | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
-
2006
- 2006-01-27 AR ARP060100304A patent/AR057643A1/es not_active Application Discontinuation
- 2006-01-27 EP EP06706448A patent/EP1841417A2/en not_active Withdrawn
- 2006-01-27 EA EA200701594A patent/EA015566B1/ru not_active IP Right Cessation
- 2006-01-27 BR BRPI0607043-4A patent/BRPI0607043A2/pt not_active IP Right Cessation
- 2006-01-27 MX MX2007009070A patent/MX2007009070A/es active IP Right Grant
- 2006-01-27 AU AU2006208630A patent/AU2006208630B2/en not_active Ceased
- 2006-01-27 CA CA002595330A patent/CA2595330A1/en not_active Abandoned
- 2006-01-27 JP JP2007552583A patent/JP2008528532A/ja not_active Withdrawn
- 2006-01-27 WO PCT/EP2006/000722 patent/WO2006079547A2/en not_active Ceased
- 2006-01-27 KR KR1020077019581A patent/KR20070096058A/ko not_active Withdrawn
-
2007
- 2007-06-14 IL IL183973A patent/IL183973A0/en unknown
- 2007-08-27 NO NO20074361A patent/NO20074361L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070096058A (ko) | 2007-10-01 |
| EP1841417A2 (en) | 2007-10-10 |
| WO2006079547A2 (en) | 2006-08-03 |
| AU2006208630A1 (en) | 2006-08-03 |
| JP2008528532A (ja) | 2008-07-31 |
| AU2006208630B2 (en) | 2011-09-29 |
| IL183973A0 (en) | 2008-12-29 |
| MX2007009070A (es) | 2007-09-12 |
| EA015566B1 (ru) | 2011-10-31 |
| WO2006079547A3 (en) | 2006-09-21 |
| BRPI0607043A2 (pt) | 2009-08-04 |
| EA200701594A1 (ru) | 2008-02-28 |
| AR057643A1 (es) | 2007-12-12 |
| CA2595330A1 (en) | 2006-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20074361L (no) | Lacosamid for "add-on"-terapi | |
| GB0318447D0 (en) | Therapeutic agents | |
| GB0225475D0 (en) | Therapeutic agents | |
| GB0225474D0 (en) | Therapeutic agents | |
| UY29112A1 (es) | Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica | |
| GB0108592D0 (en) | Therapeutic agents | |
| TN2010000137A1 (en) | Spiropyrrolidines and their use against hcv and hiv infection | |
| CY1110835T1 (el) | Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c | |
| GB0223038D0 (en) | Therapeutic compounds | |
| MY147247A (en) | Organic compounds and their uses | |
| EA200802428A1 (ru) | Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян | |
| MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| GB0223040D0 (en) | Therapeutic compounds | |
| BR0208142A (pt) | Combinações compreendendo um agente antidiarréico e epotilona ou derivado de epotilona | |
| UA95103C2 (ru) | Замещенные арилсульфонамиды в качестве противовирусных средств | |
| WO2007016476A3 (en) | Hepatitis c serine protease inhibitors and uses therefor | |
| EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
| TW200724543A (en) | Heterocyclic compounds and their uses as therapeutic agents | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| MXPA03008635A (es) | Compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
| UA94580C2 (ru) | Аналог 39-дезметоксирапамицина, способный преодолевать гематоэнцефалический барьер, для лечения патологического состояния, вызванного нейрогенным повреждением или заболеванием | |
| DE60317935D1 (de) | Alpha-aminoamid-derivate als mittel gegen migräne | |
| MY130957A (en) | Triazine derivatives and their application as antitelomerase agents | |
| TW200637538A (en) | Lacosamide for add-on-therapy | |
| ATE380188T1 (de) | Substituierte chinolone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |